Illumina and Applera Settle Patent Disputes
Biotech rivals Illumina, Inc. and Applera Corp. have agreed to settle two lawsuits over a partnership that went sour, penning a deal that involves royalty-free cross-licensing of key technologies and the...To view the full article, register now.
Already a subscriber? Click here to view full article